Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 859518-32-4 | MDL No. : | MFCD04972241 |
Formula : | C15H22N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 262.35 | Pubchem ID : | - |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium t-butanolate;palladium diacetate; 2-(dicyclohexylphosphino)-2'-methylbiphenyl; In 1,2-dimethoxyethane; at 95.0℃; for 16.0h; | A mixture of 3-(6-bromo-2-pyridyl)-l-trityl-pyrazolo[5,4-b]pyridine (100 mg, 0.1933 mmol) and (2S)-2-pheny]piperazine (54.56 mg, 0.2320 mmol) in DME (2.500 mL) was treated with sodium t-butoxide (27.87 mg, 0.2900 mmol) followed by dicyclohexyl-[2-(o-tolyl)phenyl]phosphane (7.046 mg, 0.01933 mmol) and Palladium acetate (4.340 mg, 0.01933 mmol). The mixture was allowed to stir at 95 degrees in a sealed tube overnight. The mixture was allowed to cool, filtered through celite and concentrated to give a yellow oil. This was taken up in DCM (6ml) and cooled to 0 0C. Triethylsilane (0.12 mL) and TFA (1 mL) were added and the reaction stirred at O0C for 1 hour. The solvent was removed in vacuo and the residue purified by reverse phase preparative HPLC [Waters Sunfire C 18, lOuM, IOOA column, gradient 10% - 95%B (solvent A: 0.05% TFA in water, solvent B: CH3CN) over 16 minutes at 25mL/min]. The fractions were collected, passed through a sodium bicarbonate cartridge and freeze-dried to give the title compound as a white solid (20mg, 29% Yield).ES+ 357, IH NMR (400.0 MHz, MeOH) d 8.89 (dd, J = 1.6, 8.1 Hz, IH), 8.53 (dd, J = 1.6, 4.6 Hz, I H), 7.70 - 7.66 (m, I H), 7.55 (dd, J = 4.7, 7.3 Hz, 3H), 7.46 - 7.42 (m, 2H), 7.38 - 7.34 (m, IH), 7.20 (dd, J = 4.6, 8.1 Hz, I H), 6.87 (d, J = 8.4 Hz, IH), 4.56 (s, I H), 4.55 (dd, J = 1.3, 12.7 Hz, I H), 4.42 - 4.39 (m, IH), 3.98 (dd, J = 3.0, 10.7 Hz, IH), 3.29 - 3.25 (m, IH) and 3.20 - 2.97 (m, 3H) ppm |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With potassium carbonate; In acetonitrile; at 20.0℃; for 16.0h; | To a solution of <strong>[859518-32-4]tert-butyl (R)-2-phenylpiperazine-1-carboxylate</strong> (0.30 g, 1.14 mmol) in acetonitrile (6.0 mL) was added 2,2,2-trifluoroethyl trifluoromethanesulfonate (0.33 mL, 2.29 mmol) and potassium carbonate (0.32 g, 2.29 mmol). After stirring at ambient temperature for 16 h, the reaction was diluted with ethyl acetate (20 mL) and water (20 mL). The aqueous layer was removed and the organic layer was washed with water (10 mL), brine (10 mL), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated in vacuo to dryness to afford the title compound as a colorless oil (0.389 g, 99% yield). MS (ES+) m/z 345.1 (M + 1). 1H NMR (300 MHz, CDCl3) δ 7.53-7.50 (m, 2H), 7.36-7.27 (m, 3H), 5.27-5.26 (m, 1H), 3.92-3.87 (m, 1H), 3.48-3.42 (m, 111), 3.06-2.96 (m, 3H), 2.90-2.8 1 (m, 2H), 2.58-2.50 (m, 1H), 1.48 (s, 9H); 19F NMR (282 MHz, CDCl3): δ -68.6 (s, 3F). |
[ 1240583-48-5 ]
(S)-tert-Butyl 2-phenylpiperazine-1-carboxylate
Similarity: 1.00
[ 149771-43-7 ]
tert-Butyl 3-benzyl-3,8-diazabicyclo[3.2.1]octane-8-carboxylate
Similarity: 0.92
[ 475272-55-0 ]
(S)-tert-Butyl 3-benzylpiperazine-1-carboxylate
Similarity: 0.92
[ 169447-86-3 ]
(S)-tert-Butyl 2-benzylpiperazine-1-carboxylate
Similarity: 0.92
[ 1240583-48-5 ]
(S)-tert-Butyl 2-phenylpiperazine-1-carboxylate
Similarity: 1.00
[ 149771-43-7 ]
tert-Butyl 3-benzyl-3,8-diazabicyclo[3.2.1]octane-8-carboxylate
Similarity: 0.92
[ 475272-55-0 ]
(S)-tert-Butyl 3-benzylpiperazine-1-carboxylate
Similarity: 0.92
[ 169447-86-3 ]
(S)-tert-Butyl 2-benzylpiperazine-1-carboxylate
Similarity: 0.92
[ 1240583-48-5 ]
(S)-tert-Butyl 2-phenylpiperazine-1-carboxylate
Similarity: 1.00
[ 149771-43-7 ]
tert-Butyl 3-benzyl-3,8-diazabicyclo[3.2.1]octane-8-carboxylate
Similarity: 0.92
[ 475272-55-0 ]
(S)-tert-Butyl 3-benzylpiperazine-1-carboxylate
Similarity: 0.92
[ 169447-86-3 ]
(S)-tert-Butyl 2-benzylpiperazine-1-carboxylate
Similarity: 0.92
[ 1240583-48-5 ]
(S)-tert-Butyl 2-phenylpiperazine-1-carboxylate
Similarity: 1.00
[ 475272-55-0 ]
(S)-tert-Butyl 3-benzylpiperazine-1-carboxylate
Similarity: 0.92
[ 169447-86-3 ]
(S)-tert-Butyl 2-benzylpiperazine-1-carboxylate
Similarity: 0.92
[ 947684-78-8 ]
(R)-tert-Butyl 2-benzylpiperazine-1-carboxylate
Similarity: 0.92